Cornell will host a Precision Nutrition Symposium, Oct. 14-15, designed to foster the development of collaborative and multidisciplinary working groups from Cornell’s Ithaca and New York City campuses.
C’Dots, silica-encased nanoparticles developed in the lab of engineering professor Ulrich Wiesner, have just begun their first therapeutic human clinical trial. They’re being further developed by Elucida Oncology Inc., a company co-founded by Wiesner.
Online continuing education courses developed by faculty in the Division of Nutritional Sciences (DNS) – one about infant and young child feeding for a global audience, and another about policy, systems and environmental (PSE) approaches to improving nutrition in the U.S. – address critical topics including undernutrition, maternal and child health, and childhood obesity.
Seven New York state businesses have been awarded funding to participate in the Cornell Center for Materials Research JumpStart Program, through which they will collaborate with Cornell faculty members to develop and improve their products.
Cornell food scientists have discovered that when mice are fed a high-fat diet and become obese, they lose nearly 25 percent of their tongue’s taste buds – possibly encouraging them to eat more food.
The U.S. Department of Agriculture’s National Institute of Food and Agriculture has awarded $1.8 million to two Cornell food science research projects.
The drawn-out process for diagnosing Lyme disease could become a thing of the past – good news for the thousands of people each year who get the tick-borne illness.
The National Institutes of Health has awarded a $26.5 million grant to a group that includes Weill Cornell Medicine, which aims to both silence and permanently remove HIV from the body.